Heart failure drugs show cardioprotective benefits for cancer patients undergoing treatment
By
European Society of CardiologyJun 19 2026
Summary
A presentation at ESC Cardio-Oncology 2026 demonstrated that heart failure treatments can protect heart function in cancer patients undergoing cancer therapy. Cancer treatments often cause cardiovascular side effects that may force discontinuation of anticancer therapy, reducing its effectiveness. Researchers from Erasmus University Medical Centre in Rotterdam presented findings showing cardioprotective benefits of heart failure medications for patients with cancer.
Source
Twitter / XHeart failure drugs show cardioprotective benefits for cancer patients undergoing treatmentnews-medical.netKey quotes
· 2 pulledThe cardioprotective effects of heart failure treatments in patients with cancer were demonstrated today in a presentation at ESC Cardio-Oncology 2026
Patients receiving cancer treatment often face the added complication of side effects affecting the heart, which can lead to the need to discontinue anticancer therapy, reducing its effectiveness.
You might also wanna read
Cholesterol-Lowering Drug Reduces Risk Before Heart Problems Arise
Can Heart Attack Turbocharge Mental Decline? Research Says, Maybe.
New Drug Shows Promise in Penetrating Pancreatic Cancer's 'Fibrotic Fortress'
Pancreatic cancer has an extremely low survival rate (97% mortality within 5 years for metastatic cases) due to late detection and the forma
sciencealert.com·28d ago
Las enfermedades cardiovasculares exigen vigilancia desde la mediana edad
The Use of CBD for Heart Diseases in Older Adults
Study Links Long-Term Melatonin Use to Increased Heart Failure and Mortality Risks
A preliminary study presented at the American Heart Association's Scientific Sessions 2025 found that long-term melatonin use (one year or l
Comments
Sign in to join the conversation.
No comments yet. Be the first.